Company Quick10K Filing
⚲
Ultimate Products
Filings
10-Q 2018-06-30 Filed 2018-08-20
10-K 2018-03-31 Filed 2018-07-02
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-11
10-K 2017-04-30 Filed 2017-07-21
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-K 2016-03-31 Filed 2016-06-16
10-Q 2015-12-31 Filed 2016-02-22
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-07-13
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-30
10-Q 2013-12-31 Filed 2014-02-18
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-15
10-K 2013-03-31 Filed 2013-07-01
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-13
10-Q 2011-12-31 Filed 2012-02-15
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-11
10-K 2011-03-31 Filed 2011-07-13
10-Q 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-12-07
10-Q 2010-06-30 Filed 2010-08-19
10-K 2010-03-31 Filed 2010-07-09
10-Q 2009-12-31 Filed 2010-02-16
Reports

Ultimate Products Financials

ULPC Metrics, Comps, Filings

Quarterly | Annual
Business

UPC has yet to commence planned operations to any significant measure. The Company has had only limited start-up operations and has not generated any revenues. The Company believes that it will be able to implement the business plan and conduct business pursuant to the business plan for the next 12 months with an additional capital infusion of approximately $500,000. There is no assurance that the Company will be successful in raising the additional capital and if they are not successful in raising this additional capital, they will fail.

Since becoming incorporated, the Company has not made any significant purchases or sale of assets, nor has it been involved in any mergers, acquisitions or consolidations. Ultimate Products has never declared bankruptcy, it has never been in receivership, and it has never been involved in any legal action or proceedings.

As of March 31, 2018, UPC has raised $17,300 through the sale of common stock since inception. There was no cash on hand in the corporate bank accounts. UPC currently has $90,379 in liabilities. In addition, as of the date of this annual report, we have not yet generated or realized any revenues from our business operations.

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin
Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Madison Ventures (MDSV) -0.3 0 748,143,000 0 0 -327,250,000 -289,662,000 97,057,000
Vericity (VERY) 0% 5.7 -1% 806,697,000,000 498,016,000,000 70,671,000,000 0 -11,136,000,000 -11,400,000,000 -64,552,001,000
Anvi Global Holdings (ANVI) 0.3 -162% 139,156,000 1,058,652,000 0 0 -225,126,000 -225,126,000 -69,658,000
Cardinal Ethanol (CARD) 0% -3.1 -5% 137,551,637,000 25,272,954,000 260,669,352,000 35,644,000 -6,598,913,000 5,002,326,000 -15,308,399,000
Monitronics International (MTII) 54% -3.7 -33% 1,457,388,000,000 1,088,795,000,000 428,422,000,000 229,710,000,000 -473,690,000,000 -261,950,000,000 965,324,999,000
ECCO Auto World (ECCO) 100% 0.9 -42% 43,073,000 11,771,000 10,000,000 10,000,000 -18,010,000 -18,010,000 -16,195,000
Protective Life (PL) 0% -0.5 0% 119,751,045,000,000 110,460,110,000,000 5,735,562,000,000 0 383,675,000,000 544,873,000,000 -293,299,002,000
Everflow Eastern Partners (EEPL) 51% -4.2 6% 41,677,704,000 22,380,059,000 6,257,402,000 3,206,894,000 2,357,201,000 2,800,470,000 -11,649,474,000
Reva Medical (RVA) -33% -0.3 154% 10,626,000,000 83,896,000,000 265,000,000 -88,000,000 16,394,000,000 23,305,000,000 -7,094,002,000
Heyu Biological Technology (HEYU) 44% 1.3 -33% 1,079,036,000 1,699,353,000 57,317,000 25,379,000 -357,214,000 -357,214,000 -452,320,000
Fellazo (FLLC) 14.7 -0% 280,000,000 267,199,000 0 0 -172,000 -172,000 -2,520,000
Medixall Group (MDXL) 0% 0.0 -381% 558,749,000 361,594,000 2,253,000 0 -2,129,641,000 -2,129,641,000 -50,709,000
Ultimate Products (ULPC) 0.0 -1,320% 723,000 93,204,000 0 0 -9,540,000 -9,540,000 -2,000
Bankguam (BKGMF) -10.1 1% 1,951,731,000,000 1,790,610,000,000 0 0 12,309,000,000 18,839,000,000 -189,809,002,000
Morgan Stanley Smith Barney Spectrum Select (DWSF) -1.3 14% 32,101,605,000 875,871,000 0 0 4,605,658,000 4,605,658,000 -6,133,405,000
Trine Acquisition (TRNE) -0.2 1% 304,311,637,000 10,706,577,000 0 0 2,053,393,000 2,599,231,000 -588,284,000
Vaparia (VAPA) 0.1 -34% 219,531,000 832,454,000 0 0 -74,606,000 -74,606,000 -7,442,000
Peptide Technologies (PEPT) 0.0 -22% 251,256,000 671,681,000 0 0 -56,398,000 -57,175,000 -1,055,000
Scientific Energy (SCGY) 0.2 -253% 145,768,000 1,980,009,000 0 0 -368,614,000 -365,971,000 -86,026,000
Digital Brand Media & Marketing (DBMM) 10% -1.5 -567% 110,602,000 4,347,324,000 329,232,000 32,002,000 -627,320,000 -536,897,000 820,036,000
Balance Sheet ($)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-04-302017-06-302017-09-302017-12-312018-03-312018-06-30
Cash64,00028,000020,0009,00036,000014,00038,0002,00000000000000000000
Accounts Receivable
Inventory
PP&E
Assets787,000751,000723,000743,000732,000759,000723,000737,000761,0001,125,000923,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000723,000
Accounts Payable4,900,0007,700,00010,000,00011,200,0009,400,0005,700,000
Long-Term Debt
Liabilities39,043,00043,126,00044,234,00046,636,000-46,297,00049,099,00052,299,00053,449,00056,264,00057,664,00060,164,00061,164,00062,274,00063,274,00063,474,00062,744,00067,054,00072,404,00075,104,00077,084,00078,614,00089,179,00093,204,000
Stockholders' Equity-38,256,000-42,375,000-43,511,000-45,893,00047,029,000-48,340,000-51,576,000-52,712,000-55,503,000-56,539,000-59,241,000-60,441,000-61,551,000-62,551,000-62,751,000-62,021,000-66,331,000-71,681,000-74,381,000-76,361,000-77,891,000
Income Statement ($)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-04-302017-06-302017-09-302017-12-312018-03-312018-06-30
Revenue00000000000000000000000000
Cost of Revenue
Gross Profit
R&D000000000000000
SG&A36,00036,000235,0000000
Tax00000000000000000000000
Net Income-3,136,000-4,119,000-754,000-1,246,000-1,136,000-1,311,000-3,236,000-1,136,000-2,791,000-1,036,000-2,702,000-1,200,000-1,110,000-1,000,000-200,000-2,270,000-1,510,000-5,350,000-2,700,000-1,980,000-1,530,000-1,200,000-3,850,000-2,700,000-2,815,000-1,200,000-2,825,000
Cash Flow ($)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-04-302017-06-302017-09-302017-12-312018-03-312018-06-30
Cash Operating-2,119,000-6,336,000-1,136,000-1,836,000-9,066,000-836,000-802,000-3,500,000-310,00000-3,470,000-200,000-1,620,0000-3,780,000-3,370,000-1,050,000-400,000-1,615,000-3,000,000-6,525,000
Cash Investing0000000000000000000000000
Cash Financing2,083,0006,308,0001,125,00063,0001,800,000250,0009,090,000800,000800,0003,500,000310,000003,470,000200,0001,620,00003,780,0003,370,0001,000,0001,050,000400,0001,615,0003,000,0006,525,000